Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-18T22:55:54.406Z Has data issue: false hasContentIssue false
  • English
  • Français

Detection of tetracycline and other antimicrobial residues in milk from cows with clinical mastitis treated by combination therapy

Published online by Cambridge University Press:  03 July 2018

Aleksandar Siljanoski ,
Renata Ciglarič ,
Tomaž Pezdir ,
Petra R Lainšček ,
Jožica Dolenc ,
Jože Starič  and
Ksenija Šinigoj-Gačnik
Aleksandar Siljanoski
Affiliation:
University of Ljubljana, Veterinary Faculty, Institute of Food Safety, Feed and Environment, Gerbičeva 60, 1000 Ljubljana, Slovenia
Renata Ciglarič
Affiliation:
University of Ljubljana, Veterinary Faculty, Institute of Food Safety, Feed and Environment, Gerbičeva 60, 1000 Ljubljana, Slovenia
Tomaž Pezdir
Affiliation:
University of Ljubljana, Veterinary Faculty, Institute of Food Safety, Feed and Environment, Gerbičeva 60, 1000 Ljubljana, Slovenia
Petra R Lainšček
Affiliation:
University of Ljubljana, Veterinary Faculty, Institute of Food Safety, Feed and Environment, Gerbičeva 60, 1000 Ljubljana, Slovenia
Jožica Dolenc
Affiliation:
University of Ljubljana, Veterinary Faculty, Institute of Food Safety, Feed and Environment, Gerbičeva 60, 1000 Ljubljana, Slovenia
Jože Starič
Affiliation:
University of Ljubljana, Veterinary Faculty, Clinic for Reproduction and Large Animals, Gerbičeva 60, 1000 Ljubljana, Slovenia
Ksenija Šinigoj-Gačnik*
Affiliation:
University of Ljubljana, Veterinary Faculty, Institute of Food Safety, Feed and Environment, Gerbičeva 60, 1000 Ljubljana, Slovenia
*
*For correspondence; e-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

The purpose of this study was to determine tetracycline and other antimicrobial residues in milk from dairy cows treated for clinical mastitis. Data on cow health and drugs used were obtained from the farm veterinarians. A milk sample from each affected udder quarter of each cow was taken for bacterial identification before treatment. All 35 cows in the study were treated with an intramammary product containing tetracycline, neomycin, bacitracin, and prednisolone (tetracycline injector) and also simultaneously with other drugs via the intramammary or parenteral route. The withhold period of the ‘tetracycline product’ was eight milkings but, in all cases, longer withhold periods were prescribed due to off-label application of additional combinations of drugs. Milk samples from treated udder quarters, taken two milkings before and two after the prescribed withhold period, were analysed for antimicrobial residues. Additionally, milk samples were taken from untreated healthy udder quarters to check if any crossover of drugs had occurred. Three screening tests were used for antimicrobial detection. In 15 (42·9%) cows the milk samples from the treated infected quarters contained tetracycline residues above the maximum residue limit (MRL) after the prescribed withhold period and, in two cases (5·7%) the same was true for neomycin and cefquinome residues. Cephalexin above the MRL was detected in only one case (2·9%). Beta-lactams did not exceed the MRL after the prescribed withhold period. Antimicrobial residues were not detected in milk samples from untreated quarters. Cow condition including parity, decreased milk production and severity of mastitis significantly influenced the excretion of antimicrobials in milk (P ≤ 0·05). No significant differences were found between the tetracycline positive and tetracycline negative cows regarding the bacteria involved, combination antimicrobial therapy, or treatment interval and duration.

Keywords

Milkcombined antimicrobial therapyveterinary drug residuedairy cow
Type
Research Article
Information
Journal of Dairy Research , Volume 85 , Issue 3 , August 2018 , pp. 321 - 326
Copyright
Copyright © Hannah Dairy Research Foundation 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cagnardi, P, Villa, R, Gallo, M, Locatelli, C, Carli, S, Moroni, P and Zonca, A 2010 Cefoperazone sodium preparation behavior after intramammary administration in healthy and infected cows. Journal of Dairy Science 93 4150–4110Google Scholar
du Preez, JH 1988 Treatment of various forms of bovine mastitis with consideration of udder pathology and the pharmacokinetics of appropriate drugs: a review. Journal of South African Veterinary Association 59 161–167Google Scholar
European Commission 2001 Directive 2001/82/EC. Official Journal of the European Union 2000 1–38Google Scholar
European Commission 2002 Commission Decision 2002/657/EC implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Official Journal of the European Union L221 8–36Google Scholar
European Commission 2010 Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin. Official Journal of the European Union L15 1–72Google Scholar
European Medicines Agency 2000 Note for guidance for the determination of withdrawal periods for milk, committee for veterinary medicinal products (EMEA/CMVP/473/98-final)Google Scholar
Food and Drug Administration 2015 Milk Drug Residue Sampling Survey. Department of Health and Human Services, Silver Spring MD, USAGoogle Scholar
Gaudin, V, Maris, P, Fuselier, R, Ribouchon, J-L, Cadieu, N & Rault, A 2004 Validation of microbiological method: the STAR protocol, a five-plate test for screening of antibiotics in milk. Food Additives and Contaminants 21 422–433Google Scholar
Gehring, R & Smith, GW 2006 An overview of factors affecting the disposition of intramammary preparations used to treat bovine mastitis. Journal of Veterinary Pharmacology and Therapeutics 29 237–241Google Scholar
Gips, M & Soback, S 1999 Norfloxacin pharmacokinetics in lactating cows with sub-clinical and clinical mastitis. Journal of Veterinary Pharmacology and Therapeutics 22 202–208Google Scholar
Guterbock, WM, Van Eenennaam, AL, Anderson, RJ, Gardner, IA, Cullor, JS & Holmberg, CA 1993 Efficacy of intramammary antibiotic therapy for treatment of clinical mastitis caused by environmental pathogens. Journal of Dairy Science 76 3437–3444Google Scholar
Halasa, T, Huijps, O, Østerås, O & Hegeveen, H 2007 Economic effects of bovine mastitis and mastitis management: a review. The Veterinary Quarterly 29 18–31Google Scholar
Johnson, ME, Martin, JH, Baker, R & Parsons, JG 1977 Persistence of antibiotics in milk from cows treated late in the dry period. Journal of Dairy Science 60 1655–1661Google Scholar
Kirbiš, A, Marinšek, J & Flajs, VC 2005 Introduction of the HPLC method for the determination of quinolone residues in various muscle tissues. Biomedical Chromatography 19 259–265Google Scholar
Kissell, LW, Leavens, TL, Baynes, RE, Riviere, JE & Sminth, GW 2015 Comparison of pharmacokinetics and milk elimination of flunixin in healthy cows and cows with mastitis. Journal of the American Veterinary Medical Association 246 118–125Google Scholar
Lohuis, JACM, van Werven, T, Brand, A,. Van Miert, ASJPAM, Rohde, E, Ludwig, B, Heizmann, P & Rehm, WF 1991 Pharmacodynamics and pharmacokinetics of carprofen, a non-steroidal anti-inflammatory drug, in healthy cows and cows with Escherichia coli endotoxin-induced mastitis. Journal of Veterinary Pharmacology and Therapeutics 14 219–229Google Scholar
Lucas, MF, Errecalde, JO & Mestorino, N 2009 Pharmacokinetics of azithromycin in lactating dairy cows with subclinical mastitis caused by Staphylococcus aureus. Journal of Veterinary Pharmacology and Therapeutics 33 132–140Google Scholar
MacNeil, J, Martz, VK, Korsrud, GO, Salisbury, DC, Oka, H, Epstein, RL & Barnes, CJ 1996 Chlortetracycline, oxytetracycline, and tetracycline in edible animal tissues, liquid chromatographic method: collaborative study. Journal of AOAC International 79 405–417Google Scholar
McEwen, SA, Black, WD & Meek, AH 1991 Antibiotic residue prevention methods, farm management, and occurrence of antibiotic residue in milk. Journal of Dairy Science 74 2128–2137Google Scholar
McEwen, SA, Black, WD & Meek, AH 1992 Antibiotic residues (bacterial inhibitory substances) in the milk of cows treated under label and extra-label conditions. The Canadian Veterinary Journal 33 527–534Google Scholar
National research council 2001 Nutrient Requirements of Dairy Cattle. 7th edn, pp. 258–280. Washington: National Academy PressGoogle Scholar
Oliveira, L & Ruegg, PL 2014 Treatments of clinical mastitis occurring in cows on 51 large dairy herds in Wisconsin. Journal of Dairy Science 97 5426–5436Google Scholar
Oliver, SP, Duby, RT, Prange, RW & Tritschler, JP 1984 Residues in colostrum following antibiotic therapy. Journal of Dairy Science 67 3081–3084Google Scholar
Oliver, SP, Maki, JL & Dowlen, HH 1990 Antimicrobial residues in milk following antimicrobial therapy during lactation. Journal of Food Protection 53 693–696Google Scholar
Perme, T, Bizjak, M, Gačnik, KŠ & Kirbiš, A 2010 Validation of TwinsensorBT, screening test for the detection of β-lactams and tetracyclines in milk, and comparision to Delvotest SP-NT. Slovenian Veterinary Research 47 97–106Google Scholar
Pezdir, T, Gačnik, KŠ & Dolenc, J 2012 Determination of twelve beta lactam antibiotics with LC-MS-MS. In Proceedings Euroresidue VII, conference of residues of veterinary drugs in food; Egmond aan Zee, pp. 733–737. The Netherlands. ISBN: 978-94-6173-318-4Google Scholar
Petrovski, K, Trajcev, M & Buneski, G 2006 A review of the factors affecting the costs of bovine mastitis. Journal of South African Veterinary Association 77 52–60Google Scholar
Podpečan, O, Pengov, A, Zrimšek, P, Sekulovski, P & Kirbiš, A 2014 Influence of prolonged treatment protocols on maximum residue levels of amoxicillin concentrations in bovine milk. Slovenian Veterinary Research 51 65–72Google Scholar
Poelarends, JJ, Hogeveen, H, te Giffel, M 2001 The effect of a combined intramammary and intramuscular treatment of mastitis on excretion of antibiotics in milk. Iin Proceedings of the 2nd International Symposium on Mastitis and Milk Quality, pp. 269–273Google Scholar
Rajala-Schultz, PJ, Gröhn, YT, McCulloch, CE & Guard, CL 1999 Effects of clinical mastitis on milk yield in dairy cows. Journal of Dairy Science 82 1213–1220Google Scholar
Raspor Lainšček, P, Biasizzo, M, Henigman, U, Dolenc, J & Kirbiš, A 2014 Implementation of the Bacillus cereus microbiological plate used for the screening of tetracyclines in raw milk samples with STAR protocol – the problem with false-negative results solved. Food Additives & Contaminants: Part A 31 1840–1849Google Scholar
Serraino, A, Giacometti, F, Marchetti, G, Zambrini, VA, Zanirato, G, Fustini, M & Rosmini, R 2013 Survey on antimicrobial residues in raw milk and antimicrobial use in dairy farms in the Emilia-Romagna region, Italy. Italian Journal of Animal Science 2 e68Google Scholar
Seymour, EH, Jones, GM & McGilliard, ML 1988 Persistence of residues in milk following antibiotic treatment of dairy cattle. Journal of Dairy Science 71 2292–2296Google Scholar
Založnik, B, Bajc, Z & Gačnik, KŠ 2007 Determination of tetracycline residues in food of animal origin by LC-MS/MS. In Book of abstracts of the 15th International Symposium Spectroscopy in Theory and Practice, p. 82. Nova Gorica, Slovenija, ISBN 978–961-6311-44-1Google Scholar
Ziv, G 1975 Pharmacokinetic concepts for systemic and intramammary antibiotic treatment in lactating and dry cows. In Proceedings of the IDF seminar on mastitis control, pp. 314–340Google Scholar
Ziv, G & Sulman, FG 1975 Absorption of antibiotics by the bovine udder. Journal of Dairy Science 58 1637–1644Google Scholar
Supplementary material: PDF

Siljanoski et al. supplementary material

Siljanoski et al. supplementary material 1

Download Siljanoski et al. supplementary material(PDF)
PDF 108.9 KB